ISPE Annual Meeting & Expo

Off
On behalf of the event program committee and the ISPE International Board of Directors, we want to thank our attendees for being a part of our biggest event of the year and for supporting continuous innovation and...
iSpeak Blog

By the ISPE Regulatory Team

ISPE’s regulatory volunteer groups are charged with bringing visibility and solutions to major challenges faced by the industry with regard to regulatory/quality matters, and facilitating the flow of information between ISPE members and global Health Authorities. Support for that mission was on display at the 2022 ISPE Annual Meeting and...

News & Press Releases
22 October 2020
ISPE announced its 2020 ISPE Annual Meeting & Expo , taking place virtually 2–6 November 2020, will feature an unprecedented number of regulators representing a diverse mix of global health authorities providing insights on COVID-19 and other...
News & Press Releases
14 July 2020
ISPE announced in June that we would not hold any in-person events for the remainder of the 2020 calendar year in consideration of the health and safety of our program attendees, and instead will conduct these as virtual events. In making this...
News & Press Releases
09 October 2019
ISPE announced Amy Abernethy, MD, PhD, Principal Deputy Commissioner, FDA, as a newly-confirmed keynote speaker for the 2019 ISPE Annual Meeting & Expo , taking place 27–30 October 2019 in Las Vegas, Nevada USA. Dr. Abernethy, a hematologist...
News & Press Releases
03 October 2019
ISPE announced the addition of three new keynote presenters for the 2019 ISPE Annual Meeting & Expo . Taking place 27–30 October 2019 in Las Vegas, Nevada, this signature event brings together top pharmaceutical industry and regulatory leaders...
News & Press Releases
14 August 2019
ISPE announced its featured speakers for the 2019 ISPE Annual Meeting & Expo . Taking place 27–30 October 2019 in Las Vegas, Nevada, this signature event brings together top pharmaceutical industry and regulatory leaders offering compelling and...